Addressing the heterogeneity in liver diseases using biological networks
Reviewartikel, 2021

The abnormalities in human metabolism have been implicated in the progression of several complex human diseases, including certain cancers. Hence, deciphering the underlying molecular mechanisms associated with metabolic reprogramming in a disease state can greatly assist in elucidating the disease aetiology. An invaluable tool for establishing connections between global metabolic reprogramming and disease development is the genome-scale metabolic model (GEM). Here, we review recent work on the reconstruction of cell/tissue-type and cancer-specific GEMs and their use in identifying metabolic changes occurring in response to liver disease development, stratification of the heterogeneous disease population and discovery of novel drug targets and biomarkers. We also discuss how GEMs can be integrated with other biological networks for generating more comprehensive cell/tissue models. In addition, we review the various biological network analyses that have been employed for the development of efficient treatment strategies. Finally, we present three case studies in which independent studies converged on conclusions underlying liver disease.

Computational biology

Systems biology

Liver metabolism

Integrated network

Omics integration

Genome-scale metabolic model


Simon Lam

King's College London

Stephen Doran

King's College London

Hatice Hilal Yuksel

Kungliga Tekniska Högskolan (KTH)

Ozlem Altay

Kungliga Tekniska Högskolan (KTH)

Hasan Turkez

Atatürk Üniversitesi

Jens B Nielsen

Chalmers, Biologi och bioteknik, Systembiologi

Jan Borén

Wallenberg Lab.

Mathias Uhlen

Kungliga Tekniska Högskolan (KTH)

Adil Mardinoglu

Kungliga Tekniska Högskolan (KTH)

King's College London

Briefings in Bioinformatics

1467-5463 (ISSN) 1477-4054 (eISSN)

Vol. 22 2 1751-1766


Farmaceutisk vetenskap

Bioinformatik (beräkningsbiologi)

Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)





Mer information

Senast uppdaterat